CD36 and metabolic dysfunction-associated steatotic liver disease: CD36 is a central regulator in the development of nonalcoholic fatty liver disease (Zhao et al., 2018), and meanwhile, it plays an important role in the progression of liver cancer (Li et al., 2018).